Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SkinSmart Antimicrobial is a medical technology company specializing in the development of advanced skin healing solutions based on hypochlorous acid (HOCl) technology. The company's proprietary formulation provides a stable, high-purity HOCl solution that mimics the natural antimicrobial molecules produced by the human immune system. Its product portfolio includes FDA-cleared treatments for atopic dermatitis (eczema), acne, rosacea, and chronic wound care, offering a non-toxic and steroid-free alternative to traditional topical therapies. SkinSmart's technology is designed to eliminate 99.9% of bacteria and disrupt biofilms while remaining safe for sensitive skin and mucosal membranes. The company targets both the professional medical market and the consumer over-the-counter segment, positioning itself as a leader in physiological skin antisepsis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skinsmart.